EUVIMEDEUVIMED entdecken
Crossref

Optimizing Blinatumomab Access for Low- and Middle-Income Countries: Feasibility of a Shortened, Vial-Sharing, Outpatient Approach for Pediatric ALL

Julia Esther Colunga Pedraza iD, Andrés Gómez-De León iD, Perla Rocío Colunga Pedraza iD, Ingrid Gabriela López Reyna iD, Claudia Gabriela Martínez Martínez, Yahaira Valentina Jiménez Antolinez iD, José Carlos Jaime-Pérez, David Gómez Almaguer iD, Óscar González Llano iD

JCO Global Oncology · 2026

DOI: 10.1200/go-25-00469 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JCO Global Oncology, 2026. Verfasst von Julia Esther Colunga Pedraza und 8 weiteren Autor:innen. Beteiligte Einrichtung: Hematology Department, Facultad de Medicina y Hospital Universitario Dr José Eleuterio González, Universidad Autónoma de Nuevo León, Monterrey, Mexic…. Hauptthemen laut MEDLINE: Antibodies, Bispecific, Precursor Cell Lymphoblastic Leukemia-Lymphoma. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 22 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE This study aims to evaluate the safety, feasibility, effectiveness, and cost-saving potential of a shortened, vial-sharing outpatient blinatumomab regimen for treating relapsed or refractory (R/R) ALL in children. MATERIALS AND METHODS We conducted a retrospective study of pediatric patients with R/R B-cell ALL (B-ALL) treated with a shortened outpatient blinatumomab regimen (

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antibodies, BispecificPrecursor Cell Lymphoblastic Leukemia-LymphomaHumansChildFemaleRetrospective StudiesMaleChild, PreschoolFeasibility StudiesAdolescentDeveloping CountriesOutpatientsHematopoietic Stem Cell TransplantationInfant

Substanzen

blinatumomabAntibodies, Bispecific

Autor:innen und Institutionen

  • Hematology Department, Facultad de Medicina y Hospital Universitario Dr José Eleuterio González, Universidad Autónoma de Nuevo León, Monterrey, Mexico.

ORCID-Profile: Julia Esther Colunga Pedraza, Andrés Gómez-De León, Perla Rocío Colunga Pedraza, Ingrid Gabriela López Reyna, Yahaira Valentina Jiménez Antolinez, David Gómez Almaguer, Óscar González Llano

Zitieren

APA

Colunga Pedraza, J. E., Gómez-De León, A., Colunga Pedraza, P. R., López Reyna, I. G., Martínez Martínez, C. G., Jiménez Antolinez, Y. V., Jaime-Pérez, J. C., Gómez Almaguer, D., & González Llano, Ó. (2026). Optimizing Blinatumomab Access for Low- and Middle-Income Countries: Feasibility of a Shortened, Vial-Sharing, Outpatient Approach for Pediatric ALL. JCO Global Oncology. https://doi.org/10.1200/go-25-00469

Vancouver

Colunga Pedraza JE, Gómez-De León A, Colunga Pedraza PR, López Reyna IG, Martínez Martínez CG, Jiménez Antolinez YV, et al. Optimizing Blinatumomab Access for Low- and Middle-Income Countries: Feasibility of a Shortened, Vial-Sharing, Outpatient Approach for Pediatric ALL. JCO Global Oncology. 2026. doi:10.1200/go-25-00469

BibTeX
@article{ColungaPedraza2026,
  author = {Colunga Pedraza, Julia Esther and Gómez-De León, Andrés and Colunga Pedraza, Perla Rocío and López Reyna, Ingrid Gabriela and Martínez Martínez, Claudia Gabriela and Jiménez Antolinez, Yahaira Valentina and Jaime-Pérez, José Carlos and Gómez Almaguer, David and González Llano, Óscar},
  title = {Optimizing Blinatumomab Access for Low- and Middle-Income Countries: Feasibility of a Shortened, Vial-Sharing, Outpatient Approach for Pediatric ALL},
  journal = {JCO Global Oncology},
  year = {2026},
  doi = {10.1200/go-25-00469}
}
Kostenlos starten →